Specifications: | |
Stent Plaform | 316L Stainless Steel |
Coating Material | PLGA (Biodegradable) |
Coating Thickness | 4.0±1.0μm |
Drug | Sirolimus (Rapamycine) |
Drug Content | 170μg/cm2±20μg/cm2 (12mm,18mm) |
150μg/cm2±20μg/cm2 (23mm,28mm,33mm) | |
Degradation Time | >2Months |
Clinical Results in 90 Patients with CTO: | ||
Control Group | Rapa | BMS |
6 Month MACE | 0% | 0% |
6 Month TVR | 11% | 55% |
6 Month TLR | 4% | 19% |
6 Month In-Stent Restenosis | 16% | 61% |
6 Month In-Stent Late loss | 0.41mm | 1.46mm |
| |||||||||
Length | 9 | 12 | 16 | 18 | 20 | 23 | 28 | 33 | |
Diameter | |||||||||
2.50 | √ | √ | √ | √ |
| √ |
|
| |
2.75 | √ | √ | √ | √ | √ | √ |
|
| |
3.00 | √ | √ | √ | √ | √ | √ | √ | √ | |
3.50 | √ | √ | √ | √ | √ | √ | √ | √ | |
4.00 | √ | √ | √ | √ | √ | √ | √ | √ | |
